ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...
Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
The coronavirus has ground social, economic, and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of ...
The Chosun Ilbo on MSNOpinion
mRNA vaccine phase 1 again, begging US pharma?
I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Opportunities in the veterinary biologics market include mastering vaccine development through practical courses that guide participants on EU approval processes, understanding regulatory data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback